Verve Therapeutics Statistics
Total Valuation
BOM:532439 has a market cap or net worth of INR 115.77 billion. The enterprise value is 116.66 billion.
Market Cap | 115.77B |
Enterprise Value | 116.66B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
BOM:532439 has 82.08 million shares outstanding. The number of shares has decreased by -0.03% in one year.
Current Share Class | 82.08M |
Shares Outstanding | 82.08M |
Shares Change (YoY) | -0.03% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 1.10% |
Owned by Institutions (%) | 5.85% |
Float | 39.90M |
Valuation Ratios
The trailing PE ratio is 82.14 and the forward PE ratio is 51.29.
PE Ratio | 82.14 |
Forward PE | 51.29 |
PS Ratio | 6.30 |
PB Ratio | 11.00 |
P/TBV Ratio | 11.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 82.78 |
EV / Sales | 6.35 |
EV / EBITDA | 43.38 |
EV / EBIT | 50.48 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.24 |
Debt / EBITDA | 0.96 |
Debt / FCF | n/a |
Interest Coverage | 4.27 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 12.18% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 37.35M |
Profits Per Employee | 2.86M |
Employee Count | 492 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532439 has paid 488.50 million in taxes.
Income Tax | 488.50M |
Effective Tax Rate | 25.73% |
Stock Price Statistics
The stock price has decreased by -10.90% in the last 52 weeks. The beta is 0.28, so BOM:532439's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | -10.90% |
50-Day Moving Average | 1,268.36 |
200-Day Moving Average | 1,321.66 |
Relative Strength Index (RSI) | 57.41 |
Average Volume (20 Days) | 169,714 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532439 had revenue of INR 18.37 billion and earned 1.41 billion in profits. Earnings per share was 17.17.
Revenue | 18.37B |
Gross Profit | 4.67B |
Operating Income | 2.28B |
Pretax Income | 1.90B |
Net Income | 1.41B |
EBITDA | 2.66B |
EBIT | 2.28B |
Earnings Per Share (EPS) | 17.17 |
Balance Sheet
The company has 1.70 billion in cash and 2.55 billion in debt, giving a net cash position of -845.58 million or -10.30 per share.
Cash & Cash Equivalents | 1.70B |
Total Debt | 2.55B |
Net Cash | -845.58M |
Net Cash Per Share | -10.30 |
Equity (Book Value) | 10.53B |
Book Value Per Share | 127.90 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 25.44%, with operating and profit margins of 12.43% and 7.67%.
Gross Margin | 25.44% |
Operating Margin | 12.43% |
Pretax Margin | 10.33% |
Profit Margin | 7.67% |
EBITDA Margin | 14.49% |
EBIT Margin | 12.43% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.03%.
Dividend Per Share | 0.40 |
Dividend Yield | 0.03% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.03% |
Shareholder Yield | 0.06% |
Earnings Yield | 1.22% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |